Loading page…
Oncoinvent ASA 2017 Annual Report
Company: Oncoinvent ASA
Sector: Professional & technical services
Country: Norway
Year: 2017
Type: Annual Report
Pages: 65
The report describes BerGenBio's successful 2017 IPO and Oslo Stock Exchange listing, alongside a broad clinical programme of six Phase II trials. It reports that the Group had 26 employees at year end and no operating revenues in 2017. The report also highlights continued development of bemcentinib across lung cancer, breast cancer, melanoma and AML/MDS indications.
No standards or assurance data is available for this report.
Indicators available in this report:
No materiality data is available for this report.